Specific Advanced Solid Tumors
2 clinical trials · Condition
◉ Watch Specific Advanced Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors (NCT06667141) | Acrivon Therapeutics | 2024-10-08 |
| Escalating Doses of PM01183 in Combination With Gemcitabine in Patients With Specific Unresectable Solid Tumors (NCT01970553) | PharmaMar | 2011-05-01 |
Track Specific Advanced Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.